Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 52 min ago
PreprintAll rights reservedmedRxiv

Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment

4 more authors
  1. 1NYU Langone Health, Department of Pathology, Molecular Pathology and Diagnostics, 240 East 38th Street, New York, NY 10016

Related

  1. Comprehensive Molecular Profiling for Precision Diagnostics: Integrating Genomic, Proteomic, and Epigenetic Landscapes in Human Pathology
    Anandraj Vaithy K, Apoorv Shukla, Ajay Bhengra +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. 974 Integrated multimodal profiling reveals conserved type II interferon signalling, ectopic lymphoid structure formation, and actionable inflammatory endotypes in cutaneous immune-related adverse events
    James Larkin, Samra Turajlic, Teena Thakur +10
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  3. Clinical Utility of lncRNAs in Urothelial Carcinoma of the Bladder: Diagnostics, Risk Stratification, and Treatment Guidance
    Janusz Ławiński, Beata Franczyk, Abdusalam Sagr +2
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  4. Molecular profiling and access to treatment for rare cancers in Europe
    M. Morfouace, F. Hoogstoel, J. Oliveira +20
    Nature CommunicationsPeer-reviewedCC BY-NC-NDFull textGeneral biologyEpidemiology & public healthHAL
  5. Specimen quality shapes the actionable genomic landscape in comprehensive cancer genomic profiling
    Hikaru Nakahara, Hiroaki Niitsu, Masanori Motonaga +4
    NPJ Genomic MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
BibTeX
@misc{yang2026genome,
  title = {{Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment}},
  author = {Y. Yang and V. Vasudevaraja and J. Serrano and H. Mohamed and S. Kelly and G. Jour and T. Gindin and K. Park and D. Jones and X. Feng and J. Pinnell and S. Mclennan and M. Y. Tin and A. Tsirigos and M. Snuderl and K. O. Wrzeszczynski},
  howpublished = {medRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.27.26361341},
  url = {https://www.medrxiv.org/content/10.64898/2026.08.27.26361341v1},
}
RIS
TY  - UNPB
TI  - Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment
AU  - Y. Yang
AU  - V. Vasudevaraja
AU  - J. Serrano
AU  - H. Mohamed
AU  - S. Kelly
AU  - G. Jour
AU  - T. Gindin
AU  - K. Park
AU  - D. Jones
AU  - X. Feng
AU  - J. Pinnell
AU  - S. Mclennan
AU  - M. Y. Tin
AU  - A. Tsirigos
AU  - M. Snuderl
AU  - K. O. Wrzeszczynski
PY  - 2026
DA  - 2026/08/27
PB  - medRxiv
DO  - 10.64898/2026.08.27.26361341
UR  - https://www.medrxiv.org/content/10.64898/2026.08.27.26361341v1
ER  -